Program

5th Global Ministerial Patient Safety Summit 2023

The Summit consisted of two days. The focus of the first day lied on pivotal discussions and contributions provided by international, leading experts in the field of Patient Safety. The second day united ministers from all over the world.
Please find the program also for download

Day 1 – Expert-Day 23.02.2023
Day 2 – Ministerial-Day 24.02.2023

PROGRAM OF EXPERT DAY (23.02.2023)

07.30 – 08.30 h

Arrival & Registration

08.30 – 08.40 h
Plenary Hall

Opening Statement
Anne Lévy (Director-General of the Federal Office of Public Health, Switzerland)

08.40 – 09.00 h
Plenary Hall

Keynote
«Patient Safety: Writing a different future»
Sir Liam Donaldson (WHO Patient Safety Envoy, UK)

09.00 – 09.20 h
Plenary Hall

Keynote
«1st Global Patient Safety Challenge: implementing hand hygiene worldwide, 1995-2023»
Prof. Didier Pittet (Professor of Medicine (hon), Faculty of Medicine, University of Geneva, Switzerland)

09.20 – 09.45 h

Coffee Break & Transfer to breakout rooms

09.45 – 11.15 h

Sessions 1 – 5

Implementation science is a new but rapidly growing field of research and practice that aims to overcome barriers to appropriate adoption of innovations and effective practices in health care, public health and additional social sectors. To tackle the complex challenges faced when introducing changes in health systems and organizations, the interdisciplinary field of implementation science draws from organizational and systems sciences.
This session opens with an overview of the field of implementation science and its key theories, principles and approaches – with a special focus on organizational and systems science perspectives.
Additional presenters will describe applications of implementation science to patient safety challenges while highlighting why organization and systems sciences approaches were beneficial. The session will provide detailed guidance for strengthening prevailing approaches to patient safety by incorporating implementation science ideas and tools.

Session format
Panel

Session chair
• Lauren Clack (Institute for Implementation Science in Health Care, Medical Faculty, University of Zurich, Switzerland)

Presenters/speakers
• Cara C. Lewis (Senior Investigator, Kaiser Permanente Washington Health Research Institute, Washington, USA)
• Rohit Ramaswamy (Department of maternal and child health, Gillings School of Global Public Health, North Carolina, USA)
• Annemarie Fridrich (CEO, Swiss Patient Safety Foundation, Zurich, Switzerland)
• Jonathan Purtle (Global Center for Implementation Science, NYU School of Global Public Health, New York, USA)
• Pierre Chopard (Quality of Care Department, Geneva University Hospitals, Switzerland)

In this session we will show how knowledge of implementation and behavioural sciences supports and accelerates practical action in the field. We present an overview of the different implementation frameworks relevant to behaviour change and teamwork. These frameworks identify the key factors that motivate individuals, teams and organisations in the process of implementation and provide guidance on how to design and implement successful interventions. We demonstrate the value of these approaches, and identify some of the challenges, by showing how frameworks have been used to address a variety of patient safety problems.

Session format
Panel

Session chair
• Charles Vincent (Medical Science Division, University of Oxford, UK)

Presenters/speakers
• Rebecca Lawton (Director, Yorkshire Quality and Safety Research Group, University of Leeds, UK)
• Michaela Kolbe (Head of Simulation Center, University Hospital Zurich, Switzerland)
• Cordula Wagner (Professor of Patient Safety, VU University Amsterdam, Amsterdam University Medical Center, Netherlands)
• Jacquie Oliwa (Health Systems and Implementation Science Researcher, KEMRI – Wellcome Trust, University of Nairobi, Kenya)

This session examines the current evidence and case study examples of how implementation science approaches have been harnessed to make care safer for patients. Following an overview from the Chair and an expert appraisal of the implementation science evidence, case studies from Columbia, on organisational culture change, Australia, on medication safety, and Switzerland, on empowering surgical staff to monitor their units’ checklist usage, will collectively provide real-world examples of challenges and successes in improving care. The audience and experts will interactively discuss the benefits of the cases and evidence. Stakeholders from across low-, middle- and high-resource countries will find great value in this session.

Session format
Panel

Session chair
• Jeffrey Braithwaite (Director of the Centre for Healthcare Resilience and Implementation Science, Macquarie University, New South Wales, Australia)

Presenters/speakers
• Jeremy Grimshaw (Ottawa Hospital Research Institute, University of Ottawa, Canada)
• Teresa Tono (Executive Director, Centre of Hospital Management – CGH, Bogota, Colombia)
• Johanna Westbrook (Australian Institute of Health Innovation, Macquarie University, Sydney, Australia)
• David Schwappach (Institute of Social and Preventive Medicine, University of Berne, Switzerland)

The Covid-19 pandemic highlights all patient safety issues in low-, middle- and high-income countries. This session will explore the following topics:
• Implication of Covid-19 Pandemic for Patient Safety – Scientific brief – WHO
• Official approval of drugs with low evidence
• Impact on immunization programmes
• Healthcare workforce shortage, physical and mental health of healthcare workers and its impact on patient safety
• Diagnosis Errors: Implications from COVID Era and Future Directions for Harm Reduction
Others fields will be covered by other sessions during this summit.

Session format
Panel

Session chair
• Sarah Tschudin Sutter (Deputy Head Division of Infectious Diseases & Hospital Epidemiology; University Hospital Basel, Switzerland)
• Pierre Parneix (Head of the Nouvelle Aquitaine healthcare-associated infection control center (CPIAS NA), University Hospital of Bordeaux, France)

Presenters/speakers
• Neelam Dhingra (Unit Head, Patient Safety Flagship, WHO, Geneva, Switzerland)
• Shin Ushiro (Director of the Division of Patient Safety, Kyushu University, Fukoka, Japan)
• Ramanan Laxminarayan (One Health Trust, Center for Disease Dynamics, Economics & Policy, USA)
• Howard Catton (CEO, International Council of Nurses, Switzerland)
• Hardeep Singh (Center for Innovations in Quality, Effectiveness and Safety, Houston, USA)

Antibacterial resistance (ABR), as a result of transmission and selection pressure is a global threat, leading to a silent pandemic. ABR continues to increase in clinical settings and in some countries, healthcare-associated infections (HAIs) due to resistant pathogens have become more common than HAIs due to susceptible pathogens. The balance between improving access to effective antibiotics while reducing their excessive or inappropriate use is far from being achieved. This session will explore the following topics:
• Clinical and health-economic burden of ABR
• Access – who should get more antibiotics
• Excess – who should get less antibiotics
• Impact of the CoVID-19 pandemic and the AMR Global Action Plan on antibiotic use and resistance

Session format
Panel

Session chairs
• Loice Achieng Ombajo (Infectious disease specialist, Department of Clinical Medicine and Therapeutics, University of Nairobi, Kenya)
• Abdul Ghafur (Consultant in Infectious Diseases, Apollo Hospitals, Chennai, India)
• Pierre Tattevin (French Language Society of Infectious Pathology, Alliance for the Prudent Use of Antibiotics)

Presenters/speakers
• Marlieke de Kraker (Senior epidemiologist, Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland)
• Arjun Srinivasa (Deputy Director for Program Improvement, Division of Healthcare Quality Pro-motion, US Centers for Disease Control and Prevention, Atlanta, USA)
• Christopher Butler (Department of Primary Care Health Sciences, University of Oxford, UK)
• Katie J. Suda (Clinical and Translational Science Institute, University of Pittsburgh, USA)

11.15 – 11.35 h

Opportunity for transfer between sessions/rooms

11.35 – 13.05 h

Session 6 – 10

Creating the conditions and establishing the structures, processes, capacity and capability required to make safety and quality the organisation’s imperative is crucial.
This session will describe the journey of three organisations who have set out to build their foundations for safety and create sustainability in quality improvement. The session will explore the approaches taken to develop the mindsets, values, behaviours, knowledge and skills to prepare healthcare staff at all levels of the organisation to become fully engaged, in partnership with patients and families, in a quality and safety approach. The session will also explore the importance of healthcare workforce safety and well-being in capacity and capability building.

Session format
Panel

Session chair
• Carrie Marr (University of Technology Sydney, based in Glasgow, UK)

Presenters/speakers
• Ezequiel Garcia Elorrio (Institute for Clinical Effectiveness and Health Policy IECS, Buenos Aires, Argentina)
• Lisa Schilling (Vice President, Healthcare Performance Improvement, Kaiser Permanente Institute, Oakland, USA)
• Chris Gordon (Director of Improvement at Barts Health, NHS, London, UK)

This workshop will challenge participants to analyse the Scottish national strategy for Patient Safety. How should a national strategy be developed? How can the political decision-makers and those who receive and deliver care be involved in order to obtain their support? How can a reliable and sustainable implementation of this strategy be ensured? What are the lessons from Covid about the Governance of the macro-system for the rapid implementation of Patient Safety Interventions? The workshop will use the Scottish Patient Safety Programme as a worked example and allow time for groups of participants to discuss and share how the lessons from Scotland could apply to their context.

Session format
Workshop

Session chair
• Anthony Staines (Patient Safety Program Director, Vaud Hospital Federation, Lausanne, Switzerland)

Presenters/speakers
• Jason Leitch (National Clinical Director, Scottish Government, Edinburgh, UK)
• Carol Haraden (Senior Fellow, Institute for Healthcare Improvement IHI, Cambridge, USA)
• Linda Pollock (Director, Healthcare Quality and Improvement, Scottish Government, Edinburgh, UK)

Comprehensive governance approaches to ensure implementation of patient safety concepts are key to achieving policy goals and directly affects the health system’s capacity to overcome challenges. Strong, yet adaptable, governance models contribute to health system resilience by ensuring health care systems have the capacity to respond to changing environments and challenges with limited resources. The coronavirus pandemic has placed substantial strains on health care workforce and resources, revealing and exacerbating the real patient safety risks that come with health care. The experience of this significant crisis has served as a mechanism for changes in terms of regulation, governance, and structural resources for health care safety. The session will start by OECD presenting the main findings of the 2019 report “Governing towards patient safety” and the 2023 complementing report “Advancing patient safety governance in the COVID-19 context”, followed by reactions from three invited experts.

Session format
Panel

Session chair
• Anne Lévy (Director-General, Federal Office of Public Health, Bern, Switzerland)

Presenters/speakers
• Niek Klazinga (Health Care Quality Indicator Programme, OECD, Paris, France)
• Kate de Bienassis (Health Care Quality Indicator Programme, OECD, Paris, France)
• Shin Ushiro (Director of the Division of Patient Safety, Kyushu University, Fukoka, Japan)
• Ingo Härtel (Deputy Head Division for Health Law, Patients’ Rights, Patient Safety, German Federal Ministry of Health)
• Patricia J. Garcia (School of Public Health, Cayetano Heredia University, Peru)

COVID-19 has been the biggest public health crisis our globe has faced in generations, and the greatest peacetime challenge for healthcare systems, since many decades. It has disrupted our lives to an extent few predicted; closed businesses and damaged livelihoods; and, most tragically of all, it has been associated with the deaths of almost 20 million people worldwide. Many deaths could have been avoided if healthcare systems had been better prepared and hospitals better protected. This session will describe the lessons learnt from the COVID-19 pandemic and explore future perspectives to increase preparedness and resilience.

Session format
Panel

Session chairs
• Evelyn Wesangula (Senior Antimicrobial Resistance Control Officer, East Central and Southern Africa Health community (ESC-HC))
• Vincent Cheng (Infection Control at Queen Mary Hospital, Department of Microbiology, University of Hong Kong)

Presenters/speakers
• Marc Mendelson (Division of Infectious Diseases & HIV Medicine, Department of Medicine University of Cape Town,South Africa)
• Eli Perencevich (Clinical and Health Services Research, Center for Access & Delivery Research and Evaluation, University of Iowa, USA)
• Helena Legido-Quigley (Saw Swee Hock School of Public Health, National University of Singapore, Singapore)
• Daniel Benamouzig (Director of Research at the CNRS and Chair of Sciences Po Health, France)

Antibiotic stewardship is a major component of the multifaceted strategies targeting antibacterial resistance (ABR). The principles of appropriate drug selection, sufficient dosage, adaptation to microbiology findings, and optimal treatment duration have been proven effective in both patient outcome and combating ABR. Elements of successful antibiotic stewardship programmes will be outlined, while challenges related to their implementation will be discussed in the light of real-life experiences coming from both high- and low-and-middle-income countries.

Session format
Panel

Session chair
• Yehuda Carmeli (Head, National Institute for Antibiotic Resistance and Infection Control, Israeli Ministry of Health, Tel Aviv, Israel)
• Peter Beyer (Deputy Executive Director, Global Antibiotic R&D Partnership, Switzerland)

Presenters/speakers
• Benedikt Huttner (Team Lead EML, WHO, Geneva, Switzerland)

Success stories

  • Thailand: Anucha Apisarnthanarak (Division of Infectious Diseases, Faculty of Medicine, Thammasat University Hospital, Pathum Thani, Thailand)
  • Japan: Kazuaki Jindai (Department of Virology, Tohoku University Graduate School of Medicine, Sendai – Department of Healthcare Epidemiology, School of Public Health, Kyoto University, Japan)
  • South Africa: Natalie Schellack (Division of Clinical Pharmacy, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa)
  • Latin America: Valeria Fabre (Associate Director Antimicrobial Stewardship Program, The Johns Hopkins Hospital, Baltimore, USA)

13.05 – 14.35 h

Lunch Break & Networking

14.35 – 16.05 h

Session 11 – 15

This session focuses on the implementation of the WHO Surgical Safety Checklist as an ‘exemplar’ case-study for understanding implementation and scale-up processes in global patient safety. The session features clinical, academic and policy perspectives on implementing the Checklist as an evidenced intervention. Speakers will present their own ‘hands-on’ experiences in leading national implementation programmes of the Checklist across different African countries, and lessons learnt. The session is designed for delegates interested in the designing and evaluating the impact of national scale-up safety programmes, and delegates focused on improving perioperative safety.

Session format
Panel

Session chair
• Nick Sevdalis (Director, Centre for Implementation Science, King’s College London, UK)

Presenters/speakers
• Tihitena Negussie Mammo (Global Clinical Director; Lifebox Foundation, Addis Abbeba, Ethiopia)
• Michelle White (Health Service and Population Research, Kings’ College, London, UK)
• Pierre M’Pele (Epidemiologist, Mercy Ships Regional Director for Africa, Congo)

Patient safety issues arise in mental health services on a continuum from community-based programs, through various levels of treatment, to acute in-patient facilities.
In the community, people living with mental health conditions suffer from a large treatment gap, everywhere in the world, but especially in countries with low resources. Not having access to treatments has serious consequences for the safety of vulnerable persons with serious mental disorders.
Whether in the community or in facilities, treatments for mental health conditions can have important implications for patient safety. However, safety and quality issues seldom explicitly inform the delivery of pharmacological and psychological treatments in real life, especially in low- and middle-income countries.
Many people with mental health conditions also require social interventions for housing, employment support and social benefits at different phases in their pathways to social inclusion. These often involve substantial risks and need to be implemented carefully to avoid compromising safety.
The COVID pandemic has imposed new burdens on the mental health of populations, while disrupting health services and widening care disparities. These impacts have profound implications for patient safety globally, especially in countries with slim resources already stretched to maintain fragile mental health services.
There is no doubt that patient safety deserves greater attention in global mental health. We will present three case studies to illustrate challenges and innovative practical solutions and implementation efforts to improve patient safety in the community and in treatment facilities. We also address implications of the COVID pandemic on safety in mental health services and discuss how patient safety can become an integral component of health system planning and development.

Session format
Panel

Session chair
• Sudipto Chatterjee (National Institute of Advanced Studies, Bangalore, India)

Presenters/speakers
• Randi-Luise Møgster (Deputy CEO, Haukeland University Hospital, Bergen, Norway)
• Vibeke-Iren Hellesund (Kronstad district psychiatric center at Haukeland University Hospital, Bergen, Norway)
• Hervitra Diatri (Head of Community Psychiatry Division, Department of Psychiatry, University of Indonesia, Jakarta, Indonesia)
• Neerja Chaudhary (Technical Officer, Department of Mental Health and Substance Abuse, WHO, Geneva, Switzerland)
• Rajesh Sagar (All India Institute of Medical Sciences, New Delhi, India)

Recognizing patient safety as an urgent global public health issue and the huge burden of patient harm on all health care systems across the world, 72nd World Health Assembly (WHA) in May 2019 adopted a resolution WHA72.6 on ‘Global action on patient safety’, also establishing World Patient Safety Day, to be observed annually on 17 September.
The Health Assembly also requested the WHO Director-General to formulate a global patient safety action plan. In May 2021, the 74th WHA approved the Decision WHA74(13) to adopt the first ever Global Patient Safety Action Plan 2021–2030 “Towards eliminating avoidable harm in health care” as the global roadmap for patient safety for the next 10 years. This WHA decision also mandates WHO to report back on progress in the implementation of the action plan to the assembly in 2023 and thereafter every two years till 2031. WHA recognized patient safety as a global health priority, and countries agreed to implement this resolution to develop sustainable patient safety systems. WHO session shares countries’ journey, the challenges and barriers faced in implementation of the WHA patient safety resolution and the decision on the global action plan, the lessons learned and possible solutions.

Session format
Panel

Session chair
• Neelam Dhingra (Unit Head, Patient Safety Flagship, WHO, Geneva, Switzerland)

Presenters/speakers
• Sir Liam Donaldson (WHO Patient Safety Envoy, UK)
• Aidan Fowler (National Director of Patient Safety in England, Department of Health and Social Care, London, UK)
• Rosey Benneyworth (Interim Chief Investigator, Healthcare Safety Investigation Branch, UK)
• Evelyn Dinah Nelima Wesangula (Senior Antimicrobial Resistance Control Officer, East Central and Southern Africa Health community (ESC-HC))
• Piyawan Limpanyalert (CEO, The Healthcare Accreditation Institute, Bangkok, Thailand)
• Birgit Vogt (Bundesärztekammer, Scientific Secretary of the Coordination Group for the Implementation of the Action Plan AMTS, GER)

Infection prevention and control (IPC) strategies to prevent healthcare-associated infections (HAIs) are well described; however, their implementation remains a challenge in many healthcare settings. Reasons for failure are many, and often due to a lack of knowledge and training in implementation strategies. The principles of implementation science will be presented, and reports from both high- and low-and-middle-income countries are presented. COVID-19-related experiences and challenges will also be discussed.

Session format
Panel

Session chair
• Ruth Hecker (Chairwoman of the executive board, German Coalition for Patient Safety (Aktionsbündnis Patientensicherheit e.V.); Chief Patient Safety Manager, University Hospital Essen)
• Maha Talaat (Former Regional Adviser for Antimicrobial Resistance and Infection Prevention and Control at the World Health Organization, Eastern Mediterranean Region in Cairo, Egypt)
• Bassem Zayed (Coordinator, Antimicrobial Resistance and Infection Prevention and control, World Health Organization Jordan Office, Amman, Jordan)

Presenters/speakers
• Walter Zingg (Infection Control Programme, Zurich University Hospitals, Zurich, Switzerland)

Success and failure stories in implementing the core components for infection and sepsis control and prevention:

  • Senegal: Babacar Ndoye (Consultant at WHO Africa, Brazzaville, Kongo)
  • Mexico: Hilda Marquez (Coordinator of the Master’s Degree in Quality Management and Patient Safety, Universidad de Guadalajara, Mexico)
  • Chile: Fernando Otaiza (Advisor to the Ministry of Health of Chile and the Panamerican Health Organization, Ministry of Health, Chile)
  • Turkey: Emine Alp (Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Erciyes University, Kayseri, Turkey)

WHO global strategy, action plan and monitoring framework for IPC: Benedetta Allegranzi (Deputy lead First Global Patient Safety Challenge, Integrated Health Services, WHO, Geneva, Switzerland)

During two parallel workshops, small groups of experts will discuss the following topics on healthcare-related antibiotic resistance (ABR):
• 15a: The impact of the COVID-19 pandemic on the Global Patient Safety Agenda
• 15b: National AMR action plans : progress, practices and challenges

15a The impact of the CoVID19 pandemic on national implementations of the Global Patient Safety Agenda – a 2023 reality check
Moderators:
• Susanna Lorenzo Martinez (Head of the Quality and Patient Management Area. Hospital Universitario Fundación Alcorcon (Madrid, Spain)
• Kadar Marikar (Consultant, Malaysian Society for Quality in Health, Malaysia)

15b National AMR action plans- progress, practices and challenges
Moderators:
• Javier Yugueros-Marcos (Antimicrobial Resistance and Veterinary Products Department in WOAH, France)
• Sarah Paulin (Antimicrobial Resistance, WHO, Geneva, Switzerland)
• Mirfin Mpundu (Director of ReAct Africa, University of KwaZulu Natal, South Africa)

16.05 – 16.35 h

Coffee Break & Networking

16.35 – 18.00 h
Plenary Hall

Closing Plenary

Keynote
«Implementation science: enhancing the intersection between research and practice»
Prof. Dr. phil. Lauren Clack (Institute for Implementation Science in Health Care, University of Zurich, Switzerland)

Core messages
Roundtable with session chairs, 60-90 seconds pitch each

Closing keynote – “Implementation: Getting everyone on board“
«Implementation: Getting everyone on board»
Dr. Anthony Staines (Fédération des Hôpitaux Vaudois, Lausanne, Switzerland)

afterwards

Transfer to Hotels
Meeting of Chairs of all Sessions
Preparation of the core Messages for the Ministers (Ministerial Segment)

19.30 – 22.30 h

Ministerial Dinner (Head of Delegations only)
Hosted by the President of the Swiss Confederation, Mr. Alain Berset

PROGRAM OF MINISTERIAL DAY (24.02.2023)

07.30 – 08.30 h

Arrival & Registration

08.30 – 08.50 h

Opening Plenary, Plenary Hall
Opening Remarks by the President of the Swiss Confederation, Mr. Alain Berset

08.50 – 09.00 h

Keynote, Plenary Hall
Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO

09.00 – 09.15 h

Keynote “What Needs To Be Done to Improve Patient Safety”, Plenary Hall
Joe Kiani, Founder, Patient Safety Movement Foundation, USA

09.15 – 09.30 h

Core Messages from Experts to Ministers, Plenary Hall
Prof. Didier Pittet, Professor of medicine (hon), Faculty of Medicine, University of Geneva
Dr. Anthony Staines, Fédération des hôpitaux vaudois, Lausanne, Switzerland

09.30 – 10.10 h

Ministerial Panel, Plenary Hall
Ministerial Discussion on «Implementation of Patient Safety & International Cooperation – including in Crisis Situations»

10.10 – 10.50 h

Minister Photo & Coffee Break

10.50 – 11.20 h

Panel of Summit Host Countries, Plenary Hall
Discussion by Summit Host Countries on «Progress and Challenges in Patient Safety – Experiences with the Global Ministerial Summit on Patient Safety»

11.20 – 14.15 h

Ministers’ & HoDs’ Statements, Plenary Hall

14.15 – 14.30 h

Closing Plenary, Plenary Hall
Closing Remarks by the President of the Swiss Confederation, Mr. Alain Berset

14.30 – 15.30 h

Lunch Break & Networking

The Federal Office of Public Health (FOPH) would like to acknowledge its long-standing partners Didier Pittet and Stephan Harbarth (University Hospital of Geneva HUG, Infection Control Program) as well as Anthony Staines (Staines Improvement Research, long-standing consultant of the FOPH on Quality and Patient Safety) for the development of the summit’s program. Several other experts provided valuable contributions: Alaska Yasser (Saudi-Arabia), Arce Hugo E. (Argentina), Benmosbah Lotfi (Tunisia), Boryzkowski Tcheun-How (Switzerland), Buetti Niccolo (Switzerland), Canfield Carolyn (Canada), Dhingra Neelam (WHO), Fevrier Adelia (UK), Galas Murielle (Switzerland), Härtel Ingo (Germany), Kesavan Shaleel (United Kingdom), Lajolo Camila (Brazil), Likaka Andrew (Malawi), Manser Tanja (Switzerland), Marr Carrie (Australia), Metsini Aliki (Switzerland), Rana BK (India), Schwappach David (Switzerland), Sevdalis Nick (United Kingdom), Ushiro Shin (Japan), Vincent Charles (United Kingdom), Zingg Walter (Switzerland).

CONTACT

Federal Office of Public Health
Schwarzenburgstrasse 157
3003 Bern, Switzerland

pss2023@bag.admin.ch